BIHIMA Reports Strong Q1 2026 Hearing Aid Sales
BIHIMA data for Q1 2026 shows increases in ROI sales and UK private sales compared to Q4 2025, with a notable rise in NHS adoption of rechargeable devices.
BIHIMA data for Q1 2026 shows increases in ROI sales and UK private sales compared to Q4 2025, with a notable rise in NHS adoption of rechargeable devices.
The recognition from the Business Intelligence Group highlights the company’s performance metrics and support for hearing professionals.
At AAA 2026, a panel of industry executives explored the impact of artificial intelligence, a looming talent shortage, and the critical need to reframe hearing loss as a core health issue.
The recognition from the University of Michigan honors Hochmair's contributions to hearing implant technology; she also delivered the university's graduate keynote address.
The resolution acknowledges the organization’s contributions to the hearing aid specialist profession.
Findings from the state's mandated program demonstrate a decreased age at first audiology visit and increased detection of mild hearing loss in infants.
The audiologist and researcher was hired to help accelerate the company’s clinical research in aural rehabilitation.
The students were recognized for research on surgical barriers, sentence recognition, and Medicare qualification criteria.
The Rooted & Regulated Retreat will offer mind/body practices and nervous system regulation tools for hearing healthcare professionals.